Although detailed mechanisms underlying these effects are yet to be elucidated, these findings imply that aberrant expression of GAG synthases, such as CHSY1, could provide a molecular basis for targeting PDGFRA pathway in glioma. This evidence concerns the gene CHSY1 and central nervous system cancer.